Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Sarepta Therapeutics Inc (SRPT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sarepta's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
81.70 +3.20    +4.08%
16:00:02 - Closed. Currency in USD ( Disclaimer )
After Hours
81.90
+0.20
+0.24%
16:51:14 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US8036071004 
CUSIP:  803607100
  • Volume: 732,283
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 76.96 - 82.26
Sarepta 81.70 +3.20 +4.08%
Latest Release

Nov 03, 2021

EPS / Forecast

-0.6 / -1.79

Revenue / Forecast

189.41M / 178.89M

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Mar 02, 2022 12/2021 -- /  -1.18 -- /  195.74M
Nov 03, 2021 09/2021 -0.6 /  -1.79 189.41M /  178.89M
Aug 04, 2021 06/2021 -1.02 /  -1.3 164.09M /  167.07M
May 05, 2021 03/2021 -2.1 /  -1.83 146.93M /  145.81M
Mar 01, 2021 12/2020 -2.4 /  -1.8 145.14M /  150.38M
Nov 05, 2020 09/2020 -2.5 /  -1.71 143.92M /  137.76M
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SRPT Comments

Write your thoughts about Sarepta Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
AKIN SARI
SCAR Sep 30, 2021 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
120+ very soon
Ray Ray
Ray Ray Apr 07, 2021 1:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Huge Discount BUY BUY BUY!!!
Eduardo Menezes
Eduardo Menezes Apr 07, 2021 1:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good timing
Ray Ray
Ray Ray Apr 01, 2021 5:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target is 82$
Ray Ray
Ray Ray Mar 30, 2021 5:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this company is trash
Daniel Gazey
DJG93 Mar 30, 2021 5:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
On the 19th you said it will hit 100s, make up your mind
Ray Ray
Ray Ray Mar 30, 2021 5:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will but looks like it will take 3 months. But I added 100 lots more.
Daniel Gazey
DJG93 Mar 30, 2021 5:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I was hopeful it would bounce from the over reaction, bought at $91 after the dip...playing the long game now, but painful right now
Captain Capitalist
Captain Capitalist Mar 19, 2021 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going big.
Ray Ray
Ray Ray Mar 19, 2021 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
market is ********up right now. just wait couple months and it will hit 100s
Ryan Turla
Ryan Turla Mar 19, 2021 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sell on the news
Maa Paa
GiGi__GiGi Mar 19, 2021 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
link?
Marcos GG
Marcos GG Mar 10, 2021 10:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
115 !!!
Talala Rus
Talala Rus Mar 02, 2021 1:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy. Target 115-120$
Marcos GG
Marcos GG Mar 02, 2021 7:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
arkg buy yesterday
Alessandro Gallo
Alessandro Gallo Feb 25, 2021 1:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The Food and Drug Administration is scheduled to rule on Sarepta Therapeutics Inc's (NASDAQ: SRPT) new drug application for casimersen, a treatment for patients with Duchenne muscular dystrophy who have certain genetic mutations. The PDUFA goal date is Thursday, Feb. 25.
Alessandro Gallo
Alessandro Gallo Feb 23, 2021 2:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2020 financial results after the Nasdaq Global Market closes on Monday, March 1, 2021. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full year 2020 financial results and to provide a corporate update.
крипт криптович
крипт криптович Feb 14, 2021 1:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Qwerty
Lázár Csorba
Lázár Csorba Feb 10, 2021 4:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Letsgoo
Alessandro Gallo
Alessandro Gallo Jan 30, 2021 12:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CAMBRIDGE, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on January 29, 2021 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 26 individuals hired by Sarepta in January 2021. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The employees received, in the aggregate, options to purchase 20,565 shares of Sarepta's common stock, and in the aggregate, 7,760 restricted stock units (“RSUs”). The options have an exercise price of $89.40 per share, which is equal to the closing price of Sarepta's common stock on January 29, 2021 (the “Grant Date”). One-fourth of the shares underlying each employee’s option will vest on the one-year anniversary of the Grant Date and thereafter 1/48th of the shares underlyi
Willy Bell
Willy Bell Jan 30, 2021 6:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
about to take off... all aboard
Willy Bell
Willy Bell Jan 30, 2021 6:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2.7 million pump
Juan Reyes Molina
Juan Reyes Molina Jan 22, 2021 11:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sarepta is going back to the sky
Alex Bugaj
Alex Bugaj Jan 20, 2021 6:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
pre-market is good, planning to rich TP on 208 this week
Alex Bugaj
Alex Bugaj Jan 20, 2021 6:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should be resistance at 208
In Singh
InSingh Jan 20, 2021 6:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alex Bugaj  can you explain resistance at 208. Why would you say that?
Alex Bugaj
Alex Bugaj Jan 20, 2021 6:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In Singh  on 1h chart draw support & resistance levels starting from 08.01.21. It'll show what tomorrow after the market open need to TP if you are going short (it'll be about ± $104.5 per share)
agnasola helene
bryfuture Jan 19, 2021 5:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is will go back to his hight. with earning coming, it should break 100 easily soon
milky way
milky way Jan 19, 2021 5:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let's pump to $120
milky way
milky way Jan 19, 2021 5:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I smell money
Barren Wuffet
Barren_Wuffet Jan 18, 2021 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can somebody explain this fall please?
AKIN SARI
SCAR Jan 14, 2021 1:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will definetly get over 120$ very soon
agnasola helene
bryfuture Jan 14, 2021 1:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I change my mind. I'm in
agnasola helene
bryfuture Jan 14, 2021 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email